Spanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
ANACARE
1 other identifier
observational
2,000
0 countries
N/A
Brief Summary
Primary Endpoint: The main objective of this National Registry is to identify the incidence and to analyse the risk factors for anastomotic leakage in rectal cancer surgery From the operational point of view, the aim of this Registry is to systematize the collection of information on the different surgical services. This Registry claims to have National audit functions, allowing thus the knowledge of the procedures performed at each center that could enable the establishment of the best standard of care. Secondary Endpoints: To determine the real incidence of anastomotic leakage according to the different locations and techniques: uniform definition of anastomotic leakage. To analyze the preoperative risk factors of anastomotic leakage: PATIENT FACTOR. To analyse the variability in the practice of rectal anastomosis: SURGEON FACTOR. To analyse the influence of different stapling devices in rectal anastomosis: INSTRUMENTAL FACTOR To know the current treatment of anastomotic leakage and the associated morbidity and mortality. To create and validate an anastomotic leakage predictive Score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2015
CompletedFirst Posted
Study publicly available on registry
December 17, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedDecember 17, 2015
December 1, 2015
4 months
September 22, 2015
December 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of anastomotic leakage in rectal cancer surgery in a Spanish National Audit
The aim of this Registry is to systematize the collection of information on the different surgical services. This Registry claims to have National audit functions, allowing thus the knowledge of the procedures performed at each center, that could enable the establishment of the best standard of care.
1 month
Secondary Outcomes (2)
Incidence of rectal anastomotic leakage rate between different types of surgeon
1 month
Influence of different stapling devices in rectal anastomotic leakage rate
1 month
Eligibility Criteria
It is a record of the surgical procedure performed in patients undergoing rectal cancer surgery electively, resected with curative intent and anastomosis, with or without protective ileostomy. Participating Hospitals should include all patients undergoing rectal cancer surgery CONSECUTIVE during the study period. An estimated number of centers and patients a priori is not fixed; will depend on the publicity of the record between the members of the Spanish Association of Surgeons and the commitment and involvement of the researchers involved.
You may qualify if:
- Patient with not less than 18 years.
- Patients who are to undergo surgery for rectal cancer (within 15cm from the anal margin by rigid colonoscopy), elective, resected with local curative intent (R0 and R1) and anastomosis with or without proximal stoma .
- Patient permit registration information of the surgical procedure, which has been submitted by signing the written informed consent.
You may not qualify if:
- Patients underwent the following procedures:
- No resected.
- Local resection= R2.
- Resection without anastomosis
- Patients participating in a clinical trial that would alter this trial.
- Patients who are lacking basic relevant information to complete the requested data in the registry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitario La Felead
- Johnson & Johnsoncollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 22, 2015
First Posted
December 17, 2015
Study Start
January 1, 2016
Primary Completion
May 1, 2016
Study Completion
November 1, 2016
Last Updated
December 17, 2015
Record last verified: 2015-12